Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 427 M406 M433 M450 M 1.72 B Research & development ———— — Operating income 378 M486 M-175 M425 M 1.11 B Non-Operating Income, Total -4 M12 M22 M16 M 46 M Interest expense, net of interest capitalized 89 M91 M90 M2 M 272 M Non-Operating Income, excl. Interest Expenses 0000 0 Unusual income/expense -4 M12 M22 M16 M 46 M Pretax income 272 M442 M-249 M343 M 808 M Equity in earnings -13 M-11 M-6 M-11 M -41 M Taxes 81 M45 M103 M196 M 425 M Non-controlling/minority interest 3 M5 M3 M10 M 21 M After tax other income/expense ———— — Net income before discontinued operations 189 M393 M-355 M138 M 365 M Discontinued operations ———— — Net income 189 M393 M-355 M138 M 365 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 189 M393 M-355 M138 M 365 M Basic earnings per share (Basic EPS) 0.891.8-1.630.64 1.7 Diluted earnings per share (Diluted EPS) 0.881.8-1.630.64 1.69 Average basic shares outstanding 212.91 M217.73 M217.41 M214.89 M — Diluted shares outstanding 213.8 M218.11 M217.41 M216.14 M — EBITDA 630 M739 M76 M833 M 2.28 B EBIT 378 M486 M-175 M425 M 1.11 B Cost of revenue 4.17 B4.21 B4.19 B4.19 B 16.76 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 252 M253 M251 M408 M 1.16 B